Send feedback

ADA p.Val96Ala

c.287T>C · VCV3707192

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.1987 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00134%, afr)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
1
severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency

Computational evidence

Protein change
AlphaMissense0.1987likely benign
REVEL0.413indeterminate
SaProtLLR -10.46damaging
⇒ SaProt calls this damaging; AlphaMissense does not; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.89GERP 1.4, phastCons 0.007
Regional constrainto/e 0.94unconstrained · MANE · 32 kb · p 0.21 · regional, not allelic
Overall
CADD16.64PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00134% African / African-American · 1/74,852 alleles
Filtering AF 0.000292% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000211%
Overall 0.00062% 10/1,613,904 alleles · very rare exomes 8/1,461,876 · genomes 2/152,028 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0016% 62,476
African / African-Americangrpmax 0.00134% 74,852
European (non-Finnish) 0.000678% 147,500

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ADA
Protein
p.Val96Ala
Coding
c.287T>C
MANE Select
NM_000022
Type
single nucleotide variant
Location
chr20:44626531 (GRCh38)
Gene constraint
LOEUF 1.184 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 96.81 · 2 PDB
Residue 96
a β-strand
Full ADA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Severe combined immunodeficiency due to adenosine deaminase deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal
Prevalence
1-9 / 1 000 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ada-p-val96ala (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown